We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc

Delisted

ALPN was delisted on the 17th of May, 2024.

22 hedge funds and large institutions have $69.2M invested in Alpine Immune Sciences Inc in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

195% more capital invested

Capital invested by funds: $23.5M → $69.2M (+$45.7M)

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

29% more funds holding

Funds holding: 1722 (+5)

Holders
22
Holders Change
+5
Holders Change %
+29.41%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
5
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change

ALPN Hedge Fund Activity: Q2 2020 in Review

22 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q2 2020, worth a combined $69.2M — up 195% from $23.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ALPN positions and 4 closed out — a net gain of 5 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $396K. The largest seller was BVF Inc, exiting entirely with an estimated $3.28M sold.

  • 22 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q2 2020, up from 17 in Q1 2020.
  • Funds reported $69.2M of Alpine Immune Sciences Inc stock for Q2 2020, up 195% quarter-over-quarter.
  • 9 funds opened new Alpine Immune Sciences Inc positions in Q2 2020 and 4 closed out, a net change of +5 holders.
  • The largest Alpine Immune Sciences Inc buyer in Q2 2020 was Renaissance Technologies, an estimated $396K added.
  • The largest Alpine Immune Sciences Inc seller in Q2 2020 was BVF Inc, an estimated $3.28M sold.

Based on aggregated 13F filings for Q2 2020.